Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection

Infection and Immunity

Volumn 69, Issue 7, 2001, Pages 4572-4579

  Mulvey, M A ^a   Schilling, J D ^a   Hultgren, S J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BLADDER DISEASE; BLADDER EPITHELIUM; BLADDER MUCOSA; CELL INTERACTION; CONTROLLED STUDY; EPITHELIUM CELL; ESCHERICHIA COLI; GENE REARRANGEMENT; HOST RESISTANCE; INTERNALIZATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STRAIN DIFFERENCE; URINARY TRACT INFECTION;

ACUTE DISEASE; ANIMALS; CELL LINE; CYSTITIS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; INTRACELLULAR FLUID; MICE; MICE, INBRED C57BL; URINARY BLADDER; URINARY TRACT INFECTIONS;

EID: 0034978222     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.7.4572-4579.2001     Document Type: Article

References (38)

1. Endotoxin-induced shedding of viable uroepithelial cells is an antimicrobial defense mechanism
2. Urinary tract
3. The complete genome sequence of Escherichia coli K-12
4. Type 1 fimbriae mutants of Escherichia coli K12: Characterization of recognized afimbriate strains and construction of new fim deletion mutants
5. Urinary Escherichia coli causing recurrent infections - A prospective follow-up of biochemical phenotypes
6. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract
7. Bladder surface alteration following infection with Escherichia coli
8. Exploitation of mammalian host cell functions by bacterial pathogens
9. Risk factors for second urinary tract infection among college women
10. Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection
11. An electron microscopic study of the interaction between vesical epithelium E. coli
12. Pathogenetic aspects of uncomplicated urinary tract infection: Recent advances
13. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: Mutation in the dra region prevented tubulointerstitial nephritis
14. An ascending non-obstructive model for chronic pyelonephritis in BALB/c mice
15. The mammalian bladder: An accommodating organ
16. Diagnosis and treatment of uncomplicated urinary tract infection
17. Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains
18. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli
19. Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli
20. Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies
21. Recurrence of urinary tract infection in a primary care setting: Analysis of a 1-year follow-up of 179 women
22. Biochemical fingerprinting of urinary Escherichia coli causing recurrent infections in women with pyelonephritic renal scarring
23. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae
24. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli
25. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination
26. Everything you wanted to know about the bladder epithelium but were afraid to ask
27. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells
28. The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S. epidermidis
29. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli
30. From the cover: Bad bugs and beleaguered bladders: Interplay between uropathogenic Escherichia coli and innate host defenses
31. Organization and expression of genes responsible for type 1 piliation in Escherichia coli
32. The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract
33. Potential role of phase variation of type 1 pili in urinary tract infection and bacterial prostatitis
34. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism
35. Bacterial virulence in urinary tract infection
36. Cytokine responses during mucosal infections: Role in disease pathogenesis and host defence
37. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection
38. In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: Relation to urinary tract infections